CardioSignal is a health technology company developing groundbreaking solutions for early detection of heart diseases. We are based in Turku, Finland and Palo Alto, CA, United States. The CardioSignal mobile application is a CE-marked class IIa medical device for the detection of atrial fibrillation, available in over 10 countries. The technology we are developing enables a digital cardiac biomarker for other major heart diseases as well.

CardioSignal is a brand and a product by Precordior. Originally an academic spinoff, the company’s patented motion sensor technology is built on a decade of research and algorithm development.